Biotech news
Americas
Law firm Kramer Levin Naftalis & Frankel has hired life sciences attorneys Brian Slater and Gregory Sephton. 7 April 2015
Americas
Law firm Schiff Hardin has added Cindy Ahn as counsel in its intellectual property practice group. 2 April 2015
Biotech
An appeals board at the European Patent Office has said that any patent applications covering a “product-by-process” method for developing plants can be granted. 27 March 2015
Biotech
Some of the parties involved in the landmark patent case Biogen v Medeva met in London in February to discuss the dispute in front of an invited audience. Here is an overview of their memories and the lessons they learned. 25 March 2015
Americas
Massachusetts-based biotechnology company ImmunoGen has granted pharmaceutical company Takeda exclusive rights to use its antibody-drug conjugate technology to develop and commercialise cancer drugs. 25 March 2015
Americas
Law firm Latham & Watkins has added to its Washington, DC office with the appointment of patent litigator Casey Dwyer as partner. 24 March 2015
Americas
A judge at the US District Court for the Northern District of California has denied Amgen’s attempt to block entry of a biosimilar version of its drug Neupogen. 23 March 2015
Americas
The US Court of Appeals for the Federal Circuit yesterday threw out a damages sum of $48 million, some of which had been awarded to Yale University, finding that a lower court did not properly interpret the claims in the disputed patent. 17 March 2015
Americas
In the battle for marketing approval of a biosimilar version of Neupogen under the BPCIA, applicant Sandoz stymied Amgen’s chance to join the so-called patent dance. Andrew Williams of McDonnell Boehnen Hulbert & Berghoff ponders the implications. 12 March 2015
Americas
Pharmaceutical company Janssen has sued drugs businesses Celltrion and Hospira in one of the first patent infringement actions brought under the Biologics Price Competition and Innovation Act. 10 March 2015